UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $811 | -43.1% | 70,800 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $1,426 | -10.8% | 70,800 | +0.4% | 0.00% | -25.0% |
| Q4 2022 | $1,598 | -99.9% | 70,500 | +0.1% | 0.00% | +33.3% |
| Q3 2022 | $1,321,000 | +158.5% | 70,400 | +156.9% | 0.00% | +200.0% |
| Q2 2022 | $511,000 | +98.1% | 27,400 | +91.6% | 0.00% | 0.0% |
| Q1 2022 | $258,000 | +14.2% | 14,300 | +31.2% | 0.00% | – |
| Q4 2021 | $226,000 | -24.9% | 10,900 | +16.0% | 0.00% | -100.0% |
| Q3 2021 | $301,000 | – | 9,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 939,966 | $21,309,029 | 5.53% |
| Aquilo Capital Management, LLC | 624,854 | $14,165,440 | 5.32% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 631,500 | $14,297,160 | 4.42% |
| Nantahala Capital Management | 2,700,239 | $61,214,418 | 3.97% |
| Integral Health Asset Management, LLC | 550,000 | $12,468,500 | 2.62% |
| Privium Fund Management B.V. | 301,298 | $6,830,426 | 2.59% |
| 683 Capital Management, LLC | 1,145,000 | $25,957,150 | 2.20% |
| PFM Health Sciences, LP | 2,302,314 | $52,193,458 | 1.87% |
| Nantahala Capital Management | 1,187,700 | $26,925,159 | 1.74% |
| Jetstream Capital LLC | 30,000 | $680,100 | 1.44% |